United Overseas Bank Limited – Recovery on track August 5, 2021 456

PSR Recommendation: ACCUMULATE Status: Maintained
Target Price: 29.00
  • 2Q21 earnings of S$1.0bn in line, at 25.5% of our FY21e forecast. Stronger-than-expected net fee and commission income offset by lower trading and investment income. 1H21 PATMI is 51% of our FY21e forecast.
  • NIMs eased 1bp QoQ to 1.56%, though NII grew 3% in the same period led by steady loan growth mainly from term and trade loans in Singapore, North Asia and Rest of World. Guidance for FY21e unchanged.
  • Impairment provisions of 20bps below our base case of 30bps in FY21e credit cost.
  • Dividend payout returns to pre-pandemic levels. Interim DPS of 60 cents declared.
  • Maintain ACCUMULATE with higher GGM TP (1.17x of FY21e P/BV) of S$29.00 from S$28.70 after earnings revision. We raise FY21e earnings by 7% as we crank up fees and commissions estimates on the back of strong growth in WM and income and loan-related fees. Catalysts expected from a stabilisation of outlook and the reversal of GP

 

 

The Positives

+ NII increased 3% QoQ, led by steady loan growth. Loans grew 2%, underpinned by term and trade loans in Singapore, North Asia and Rest of World. NIMs, however, eased 1bp this quarter to 1.56%. They are expected to be stable in FY21e as the bank targets loan growth to improve NII. Wholesale banking operating profits grew 6% YoY to a quarterly record backed by record investment banking revenue and strong growth in loans and trade volume.

+ Fee income exceeded our forecast by S$103mn. Fee and commission income grew 34% YoY, exceeding our forecast by S$103mn. The beat came from loan-related fees which benefited from more corporate drawdowns and opportunistic underwriting activities. Fees however, were 7% weaker QoQ due to lower trading activity from WM.

+ Impairment provisions below our base case of 30bps in FY21e credit cost. Allowances were S$182mn in 2Q21 or 20bp vs. S$201mn of provisions in 1Q21 or 29bp. The S$182mn provisions comprised 7bps in GPs and 17bps in SP. The QoQ drop reflected overall resilient asset quality and strong pre-emptive general allowances taken previously.

Total general allowance for loans, including RLARs, were prudently maintained at 1% of performing loans.

+ Dividend payouts resume to pre-pandemic levels. The bank has declared an interim DPS of 60 cents vs. 1H20 interim dividend of 39 cents. This translates to a payout of 50%.

 

The Negatives

– Loans under moratorium unchanged at 6%. We believe these belonged to weaker corporates which still require loan relief. As the moratoriums begin to expire, we could see an uptick in NPLs in the remainder of FY21e.

 

Outlook

Profit outlook should improve in 2021

UOB’s profit should recover in 2021 on the back of stabilising margins, stronger fees and lower provisions. We expect WM, loan-related and card fees to expand 22% YoY. We now expect credit costs to come in below guidance of 30bps from around 55bps last year. Management seems confident that GPs of about S$900mn already made can address any increase in non-performing loans as loan moratoriums expire.

We upgrade our FY21e earnings by 7% as we crank up fees and commissions estimates on the back of strong growth in WM income and loan-related fees. We expect loans growth at 2% and NIMs to remain stable for the rest of FY21e.

 

Investment Action

Maintain ACCUMULATE with higher GGM TP S$29.00, from S$28.70

We maintain our ACCUMULATE recommendation with a higher GGM target price of S$29.00 from S$28.70 following our earnings revision. Our target price remains based on GGM (1.17x FY21e P/BV) valuation.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

About the author

Profile photo of Terence Chua

Terence Chua
Senior Research Analyst
Phillip Securities Research

Terence specialises in the consumer, conglomerate and industrials sector. He has over five years of experience as an analyst in the buy- and sell-side. As an institutional fund management analyst, he sat on the China-Hong Kong desk. Terence was ranked top 3 for Best Analyst under the small caps and energy category in the Asia Money poll 2018.

He graduated from the Singapore Management University with a major in Finance (Honours), and is the honoured recipient of the CFA scholarship.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!